OmanDocSign in

Curriculum · Respiratory

Pulmonary function test interpretation

What it is

Testing before and after a bronchodilator answers two things in order: is there obstruction, and if there is, is it reversible. The flow-volume loop adds the pattern. It shifts to the left in patients with obstructive lung disease, where there is air trapping and decreased outflow, as in asthma, and it shifts to the right in patients with restrictive lung disease, where the lung volumes are smaller. The loop plots flow in L/sec against lung volume in L, and it has an expiration part and an inspiration part.

How it is diagnosed

Obstruction is present when FEV1/FVC is below 70%; a ratio of 0.68, that is 68%, is obstruction. Whether that obstruction is reversible is read from the change in FEV1 after the bronchodilator, the % change taken as post minus pre over pre. A worked example runs like this. Pre-bronchodilator, FVC was 3.19 L against a predicted 4.22 L, that is 76% predicted; FEV1 was 2.18 L against a predicted 3.39 L, that is 64% predicted; and FEV1/FVC was 0.68 against a predicted 0.80. After the bronchodilator FVC was 4.00 L, a change of 25%, FEV1 was 2.83 L, a change of 30%, and the ratio was 0.71. So FEV1 improved by 650 ml, from 2180 to 2830, and improved by 30%, that is 650 over 2180 times 100. That is reversible obstruction, and reversible obstruction of this kind is consistent with a diagnosis of asthma. Reversibility has a number of its own: improvement in FEV1 by 200 ml AND 12% after the bronchodilator, the two together and not either alone. Restriction is the second question and it is asked of total lung capacity, not of the ratio: TLC under 80% is diagnostic of restriction and TLC is the gold standard for it, while FVC is a surrogate marker of TLC used when a full PFT is not done, so FVC under 80% is suggestive of restriction rather than diagnostic. Where there is restriction, DLCO separates pulmonary or parenchymal causes such as ILD from extrapulmonary causes such as neuromuscular disorders.